The 5-HT1A receptor antagonist WAY-100635 maleate reprograms metabolism to promote RGC differentiation and regeneration in retino-visual centers
Sayanta Dutta, Michelle L. Surma, Jie Chen, Kavitha Anbarasu, Jingwei Meng, Nian Wang, Arupratan Das
This study identifies WAY-100635 as a neuroprotectant that reprograms metabolism to promote RGC differentiation and regeneration in glaucoma models.
Communications Medicine · Apr 2, 2026Peer-reviewedNeuroscience